Sharif Kayali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sharif Kayali has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Issa Pour-Ghaz
Division of Cardiovascular Disease, University of Tennessee Health Science Center, Memphis, TN 38103, USA
3 shared publications - Christopher Nance
Department of Neurology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, IA, USA
2 shared publications Mark Heckle
Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA
2 shared publications- Rajesh Kabra
Kansas City Heart Rhythm Institute Overland Park KS USA
2 shared publications - Sunil Jha
Department of Mechanical Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India
2 shared publications Yehoshua C. Levine
Department of Internal Medicine, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA | Methodist Le Bonheur Healthcare, Memphis, TN, USA
2 shared publications
Latest Publications
- 23 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (5) , 102481
Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty – Where are we in 2024?
- 23 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (5) , 102481
Chronic thromboembolic pulmonary hypertension and balloon pulmonary angioplasty – Where are we in 2024?
- 4 January 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (3) , 501-504
A case of short QT‐interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia‐mediated imbalance
Introduction: We report the case of an 18‐year‐old female with recurrent syncope that was discovered to have congenital long QT syndrome (LQTS) and episodes of a transiently short QT interval after spontaneous termination of polymorphic ventricular tachycardia.Methods & Results: A cardiac event monitor revealed a long QT interval and initiation of polymorphic ventricular tachycardia by a premature ventricular complex on the preceding T‐wave. After 1 minute of ventricular fibrillation, her arrhythmia spontaneously terminated with evidence of a short QT interval.Conclusions: A transient, potentially artificial, short QT interval following Torsades de Pointes can occur in patients with LQTS.
- 4 January 2024
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 35 (3) , 501-504
A case of short QT‐interval postventricular arrhythmia arrest from Torsade De Pointes, a new phenotype, or the result of tachycardia‐mediated imbalance
Introduction: We report the case of an 18‐year‐old female with recurrent syncope that was discovered to have congenital long QT syndrome (LQTS) and episodes of a transiently short QT interval after spontaneous termination of polymorphic ventricular tachycardia.Methods & Results: A cardiac event monitor revealed a long QT interval and initiation of polymorphic ventricular tachycardia by a premature ventricular complex on the preceding T‐wave. After 1 minute of ventricular fibrillation, her arrhythmia spontaneously terminated with evidence of a short QT interval.Conclusions: A transient, potentially artificial, short QT interval following Torsades de Pointes can occur in patients with LQTS.
- Open Access
- 1 March 2022
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 18 (2) , 1
Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy
: Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy, even though LVEF is a better marker of total mortality than ventricular tachyarrhythmias mortality. This review evaluates imaging tools and novel biomarkers proposed for better risk stratifying arrhythmic substrate, thereby identifying optimal ICD therapy candidates.
- 1 March 2022
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 18 (2) , 1
Open AccessBeyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy
: Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy, even though LVEF is a better marker of total mortality than ventricular tachyarrhythmias mortality. This review evaluates imaging tools and novel biomarkers proposed for better risk stratifying arrhythmic substrate, thereby identifying optimal ICD therapy candidates.
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S129-S130
B-PO02-083 RACIAL DIFFERENCES IN PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION
- 1 August 2021
- Published by Elsevier in Heart Rhythm
- Vol. 18 (8) , S129-S130
B-PO02-083 RACIAL DIFFERENCES IN PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION
- Open Access
Cardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.
Open AccessCardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.
- 10 October 2020
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 22 (11) , 1-15
Role of Catheter Ablation as a First-Line Treatment for Atrial Fibrillation
- 10 October 2020
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 22 (11) , 1-15
Role of Catheter Ablation as a First-Line Treatment for Atrial Fibrillation